Anthrax Articles | Global Biodefense

Anthrax

Biodefense Headlines – April 30, 2026

News Scan April 30, 2026

This week’s selections include cascading institutional disruptions reshaping U.S. public health and science governance — including the Trump administration’s mass firing of the National Science Board and restrictions on graduate…

Anthrax

Anthrax Lethal Factor Plays Hide and Seek

New PharmAthene Anthrax Vaccine Data Published

Soligenix Submits NIAID Contract Proposal for Thermostable Ricin Vaccine

New Blood Test for Anthrax to Speed Post-Exposure Treatment

Navy Seeks CBRE Mail Screening Equipment

NIST, USAMRIID Propose New Explanation for Key Step in Anthrax Infection

PharmAthene and Theraclone Sciences Announce Merger Agreement

Animal Study Results for Intramuscular Anthrax Anti-Toxin

Biodefense News Headlines of the Week – July 21, 2013

U.S. Army to Study Biological Decontamination of Aircraft Interiors

FDA Lifts Clinical Hold On PharmAthene’s Anthrax Vaccine Program

New Kind of Antibiotic May Be More Effective Against Biothreats

Goodwin Biotechnology Awarded Sub-Contract for Anthrax Vaccine

Notable Contracts: Cempra Biodefense Antibiotic for Children

Soligenix Thermostable Biodefense Vaccine Technology Patent

GAO Says 60 Percent of CBRN National Stockpile Approved for Children

CBRN Diagnostics Broad Agency Announcement

Second Suspicious Letter Intercepted, Addressed to POTUS

Bacillus ACT 2013 – International Anthrax Conference

Biodetection Technologies for First Responders

Biodefense Headlines – April 30, 2026